Biotech Spirulina: a Highly Digestible Alternative Protein and Essential Amino Acid Source for Salmon Feeds March 21, 2023
Biotech Pond Technologies Announces Closing of Previously Announced Shares for Debt Transaction January 25, 2023
Biotech Pond Announces that AB Agri has Begun to Grow Algae Following the Delivery of a Pond Algae Lab December 14, 2022
Biotech Pond Announces that AB Agri has Begun to Grow Algae Following the Delivery of a Pond Algae Lab December 14, 2022
Biotech Pond Technologies Holdings Inc. Announces Filing of 2022 Third Quarter Unaudited Interim Condensed Financial Statements, MD&A and Provides Business Update November 29, 2022
Biotech Pond Technologies Announces Closing of Non-Brokered Private Placement Including Insider Participation November 16, 2022
Biotech Harmony Biosciences Reports Third Quarter 2022 Financial Results and Business Updates November 1, 2022
Biotech REGENXBIO Presents Additional Positive Interim Data from the Phase I/II/III CAMPSIITE(TM) Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome) at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium August 31, 2022
Biotech Denali Therapeutics Announces New Interim Data from Phase 1/2 Study of DNL310 (ETV:IDS) in MPS II (Hunter Syndrome) at SSIEM 2022 August 31, 2022